Episode
Getting To A First Product Approval With Celcuity's Brian Sullivan
- Podcast
- Business Of Biotech
- Published
- Aug 17, 2026
- Duration seconds
- 3016
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-of-biotech-123501/getting-to-a-first-product-approval-with-celcuity-s-brian-sullivan.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approval for Revtorpyk, a kinase inhibitor for breast cancer patients, and why targeting an “untreated disease mechanism” can beat chasing a single mutation. Brian also discusses the process for licensing a shelved Pfizer asset for development, designing Phase 3 trials that challenge assumptions, the benefits of...